Andere Kunden interessierten sich auch für
![Biosimilars: An overview of emerging laws]( "Biosimilars: An overview of emerging laws")
Biosimilars: An overview of emerging laws42,99 €![Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account]( "Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account")
Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account54,99 €![Analysis of the Regulatory Requirements for Biosimilars in the EU]( "Analysis of the Regulatory Requirements for Biosimilars in the EU")
Analysis of the Regulatory Requirements for Biosimilars in the EU18,99 €![Biogene Arzneimittel]( "Biogene Arzneimittel")
Biogene Arzneimittel85,00 €![Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken]( "Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken")
Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken15,95 €![The Challenge of CMC Regulatory Compliance for Biopharmaceuticals]( "The Challenge of CMC Regulatory Compliance for Biopharmaceuticals")
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals117,99 €![Ivermectin for alcohol use disorders]( "Ivermectin for alcohol use disorders")
Ivermectin for alcohol use disorders36,99 €
This review gives clear insight on Biosimilars. Biosimilars the follow-on biologicals is the new area for a pharmaceutical industry to consider whether it suits its expertise, its business interest and offers for it opportunities for growth. This review explores Biosimilar Drug Development from the view-point of a biopharmaceutical company and proposes key points that a company needs to consider through the process of planning biosimilar drug development. It examines significant developments in the biosimilars market and will arm the reader with scientific, regulatory and strategic information needed to face new opportunities as well as the challenges of the biosimilars revolution.